AIDS in era of antiretrovirals

Confronting the deadly pandemic

An estimated 1 million people die each year from HIV/AIDS, while nearly 2 million people become newly infected with the virus.

Approximately 36.9 million people were living with the human immunodeficiency virus (HIV) at the end of 2017, the majority of them in sub-Saharan Africa. While there is no cure for HIV/AIDS, a combination of drugs, known as antiretrovirals (ARVs), enable people to live longer, healthier lives. The cost of first-line drugs are now cheaper than ever, but efforts are still needed to ensure everyone who is living with HIV receives treatment. Over 15 million people missed out on receiving treatment in 2017.

 
Website

MSF Access Campaign

msfaccess.org

Quick Facts

 
Out of Darkness- fighting Hepatitis C
Ukraine

"I am one of you: I live with HIV and used to live with hepatitis C"

Voices from the Field 30 Nov 2018
 
Out of Darkness- fighting Hepatitis C
Ukraine

Mykolaiv project shows that hepatitis C can be effectively treated in people living with HIV

Project Update 30 Nov 2018
 
HIV department of Arua Regional hospital
HIV/AIDS

Treatment scale-down ahead?

Report 29 Nov 2018
 
Castors Maternity - Bangui
World AIDS Day

UNAIDS report overlooks significant aspects of the global HIV response

Statement 29 Nov 2018
 
Chiradzulu: HIV care for adolescents
HIV/AIDS

Pharmaceutical corporations are failing children with HIV

Press Release 29 Nov 2018
 
MSF HIV Testing Clinic's in Conakry
Access to medicines

HIV and TB treatment at risk as countries gradually lose Global Fund support

Press Release 13 Nov 2018
 
Diagnosing, treating and researching HIV-kala azar co-infection
Kala azar

Diagnosing, treating and researching HIV-kala azar co-infection in Ethiopia

Project Update 20 Sep 2018
 
Advanced HIV management in Homa Bay
HIV/AIDS

Stopping Senseless Deaths: Overcoming access barriers to affordable, lifesaving diagnostics and treatments for HIV and opportunistic infections

Report 23 Jul 2018
 
Tanya and Florence - Living With HIV
HIV/AIDS

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Press Release 23 Jul 2018
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our HIV/AIDS-related articles on our dedicated Field Research website.

Visit site
Advanced HIV management in Homa Bay